Back to
NORTHERN TRUST CORP
SGMOQ30 quarters
Position history for
NORTHERN TRUST CORP's holdings in SANGAMO THERAPEUTICS, INC
As of its Q1 2026 13F, Northern Trust held 737,867 shares of SGMOQ (Sangamo Therapeutics), worth $182,179. Northern Trust's 13F filings listed SGMOQ from Q1 2019 to Q1 2026, 29 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$12.6M
Total Shares Change
-1.3M
Quarter-by-Quarter History
Other major holders of SGMOQ: WASATCH ADVISORS LP, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP